−3.687 CHF
−98.18 M CHF
6.03 M CHF
8.26 M
About RELIEF THERAPEUTICS N
Sector
Headquarters
Geneva
Founded
2013
Website
ISIN
CH1251125998
FIGI
BBG006M6ZG95
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of RLF is 6.480 CHF — it has decreased by −1.29% in the past 24 hours. Watch RELIEF THERAPEUTIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange RELIEF THERAPEUTIC stocks are traded under the ticker RLF.
RLF stock has risen by 12.34% compared to the previous week, the month change is a 12.34% rise, over the last year RELIEF THERAPEUTIC has showed a 12.34% increase.
RLF stock is 17.02% volatile and has beta coefficient of −1.97. Track RELIEF THERAPEUTIC stock price on the chart and check out the list of the most volatile stocks — is RELIEF THERAPEUTIC there?
Today RELIEF THERAPEUTIC has the market capitalization of 62.70 M, it has increased by 8.88% over the last week.
Yes, you can track RELIEF THERAPEUTIC financials in yearly and quarterly reports right on TradingView.
RLF net income for the last half-year is −4.56 M CHF, while the previous report showed −41.68 M CHF of net income which accounts for 89.07% change. Track more RELIEF THERAPEUTIC financial stats to get the full picture.
No, RLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RELIEF THERAPEUTIC EBITDA is −9.26 M CHF, and current EBITDA margin is −274.92%. See more stats in RELIEF THERAPEUTIC financial statements.
Like other stocks, RLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTIC stock right from TradingView charts — choose your broker and connect to your account.